RecruitingNot applicableNCT07261891

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

Studying Primary immunodeficiency

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
prof. dr. Rik Schrijvers
Principal Investigator
Rik Schrijvers, MD, PhD
UZ Leuven
Intervention
blood sampling(diagnostic_test)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
20242030

Study locations (1)

Collaborators

Research Foundation - Flanders (Fonds Wetenschappelijk Onderzoek)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07261891 on ClinicalTrials.gov

Other trials for Primary immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Primary immunodeficiency

← Back to all trials